BRIEF — FDA Says CDER Has Established Exclusivity Board

Oct 16 (Reuters) — FDA: Fda: Cder Has Established Exclusivity Board To Provide Oversight & Recommendations Regarding Exclusivity Determinations Made By The Center Fda: Cder Board To Focus On 5-year New Chemical Entity Exclusivity, 3-year New Clinical Trial Exclusivity, & Exclusivity For Biological Products Fda: Cder Exclusivity Board May Evaluate & Make Recommendations On Cder’s Policies, Practices On Exclusivity (Reuters.Briefs@thomsonreuters.com;)